{"id":"NCT01945593","sponsor":"Baxalta now part of Shire","briefTitle":"BAX 855 Continuation","officialTitle":"A Phase 3b Continuation Study of the Safety and Efficacy of PEGylated Recombinant Factor VIII (PEG-rFVIII; BAX 855) in Prophylaxis of Bleeding in Previously Treated Patients With Severe Hemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10-15","primaryCompletion":"2018-03-02","completion":"2018-03-02","firstPosted":"2013-09-18","resultsPosted":"2019-05-01","lastUpdate":"2021-05-24"},"enrollment":218,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hemophilia A"],"interventions":[{"type":"BIOLOGICAL","name":"BAX855","otherNames":["ADYNOVATE","BAX 855","PEGylated Recombinant Factor VIII"]}],"arms":[{"label":"Fixed BAX855 prophylaxis","type":"EXPERIMENTAL"},{"label":"Pharmacokinetic (PK)-tailored BAX 855 prophylaxis","type":"EXPERIMENTAL"}],"summary":"To continue the evaluation of the safety and efficacy of BAX 855 for prophylaxis and treatment of bleeding episodes in adult and pediatric previously treated patients (PTPs) aged ≤ 75 years of age with severe hemophilia A.","primaryOutcome":{"measure":"Number of Participants With Inhibitory Antibodies to Factor VIII (FVIII)","timeFrame":"Baseline through end of study (53 months)","effectByArm":[{"arm":"BAX 855: Age < 2 Years","deltaMin":0,"sd":null},{"arm":"BAX 855: Age >= 2 to <12 Years","deltaMin":0,"sd":null},{"arm":"BAX 855: Age >= 12 to <17 Years","deltaMin":0,"sd":null},{"arm":"BAX 855: Age >= 17 Years","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":89,"countries":["United States","Australia","Austria","Bulgaria","Czechia","Germany","Hong Kong","Israel","Japan","Lithuania","Malaysia","Netherlands","Poland","Romania","Russia","South Korea","Spain","Sweden","Switzerland","Taiwan","Turkey (Türkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":3},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Cough","Arthralgia","Headache"]}}